ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Investors focused most intensely on Alphabet’s cloud services business which generated lower-than-expected revenue, a weak forecast, and aims to spend $75 billion – ...

Nvidia ( NVDA 4.00%) has gotten off to a bad start on the stock market in 2025, losing more than 10% of its value as of this writing, with Chinese artificial intelligence (AI) start-up DeepSeek's ...

Follow all the latest U.S. market action for Tuesday as stocks stage a recovery amid lingering tariff angst; Alphabet ...

What makes a stock go up? Supply and demand. More buyers means a rise in stock prices. When there are more sellers, stock ...

SailPoint said on Tuesday it was targeting a valuation of up to $11.5 billion in its New York flotation, as the cybersecurity ...

Robert Kiyosaki rose to fame in 1997 after Rich Dad Poor Dad was published. His personal finance book went on to sell over 26 million copies and remain on the New York Times best-seller list for ...

GM, Ford and Stellantis stock plunged in initial trading Monday in light of a pending trade war. But Wall Street showed some ...

For Elon Musk fans, it’s the half-trillion dollar bet. The stock market value of Tesla has surged by that much since Donald ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

President Donald Trump’s new tariffs on imports from Canada and China will go into effect on Tuesday, while the planned ...